1. Home
  2. GMM vs NVNO Comparison

GMM vs NVNO Comparison

Compare GMM & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMM
  • NVNO
  • Stock Information
  • Founded
  • GMM 2017
  • NVNO 1987
  • Country
  • GMM China
  • NVNO United States
  • Employees
  • GMM N/A
  • NVNO N/A
  • Industry
  • GMM
  • NVNO Medical/Dental Instruments
  • Sector
  • GMM
  • NVNO Health Care
  • Exchange
  • GMM Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • GMM 70.8M
  • NVNO 71.0M
  • IPO Year
  • GMM 2023
  • NVNO N/A
  • Fundamental
  • Price
  • GMM $2.86
  • NVNO $5.08
  • Analyst Decision
  • GMM
  • NVNO
  • Analyst Count
  • GMM 0
  • NVNO 0
  • Target Price
  • GMM N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • GMM 11.3K
  • NVNO 123.9K
  • Earning Date
  • GMM 07-25-2025
  • NVNO 07-30-2025
  • Dividend Yield
  • GMM N/A
  • NVNO N/A
  • EPS Growth
  • GMM 62.17
  • NVNO N/A
  • EPS
  • GMM 6.37
  • NVNO N/A
  • Revenue
  • GMM $41,360,953.00
  • NVNO N/A
  • Revenue This Year
  • GMM N/A
  • NVNO N/A
  • Revenue Next Year
  • GMM N/A
  • NVNO N/A
  • P/E Ratio
  • GMM $0.45
  • NVNO N/A
  • Revenue Growth
  • GMM 53.82
  • NVNO N/A
  • 52 Week Low
  • GMM $1.69
  • NVNO $2.03
  • 52 Week High
  • GMM $15.60
  • NVNO $6.13
  • Technical
  • Relative Strength Index (RSI)
  • GMM 55.52
  • NVNO 73.57
  • Support Level
  • GMM $2.71
  • NVNO $4.11
  • Resistance Level
  • GMM $3.29
  • NVNO $5.62
  • Average True Range (ATR)
  • GMM 0.22
  • NVNO 0.30
  • MACD
  • GMM 0.02
  • NVNO 0.10
  • Stochastic Oscillator
  • GMM 43.42
  • NVNO 78.32

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: